Real-time enrollment status for this her2-positive breast cancer clinical trial
Current Status
Recruiting
Checked: October 26, 2026 at 6:24 PM UTC
| NCT Number | NCT07895511 |
| Recruiting Status | Recruiting |
| Condition | HER2-positive Breast Cancer |
| Phase | NA |
| Target Enrollment | 136 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | October 26, 2026 (18 hours ago) |
As of October 26, 2026: Clinical trial NCT07895511 is currently recruiting participants. This na study for her2-positive breast cancer is actively seeking new participants at 7 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07895511 is actively recruiting participants as of October 26, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07895511 was last updated 18 hours ago (October 26, 2026). HelloStudys verifies this status automatically.